Bone Marrow TransplantationLeukemia, Myeloid, AcuteBone MarrowLeukemia, MyeloidTransplantation, HomologousBone Marrow CellsLeukemiaGraft vs Host DiseaseTransplantation, AutologousLeukemia, Myelogenous, Chronic, BCR-ABL PositiveWhole-Body IrradiationAcute DiseaseHematopoietic Stem Cell TransplantationTreatment OutcomeBone and BonesTransplantation ConditioningRemission InductionCytarabineAnemia, AplasticMyelodysplastic SyndromesBusulfanRecurrenceHematopoietic Stem CellsTransplantation ChimeraLiver TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaTissue DonorsCombined Modality TherapyBone Marrow PurgingGraft SurvivalPrognosisfms-Like Tyrosine Kinase 3CyclophosphamideHistocompatibility TestingGene Expression Regulation, LeukemicSurvival AnalysisRetrospective StudiesAntineoplastic Combined Chemotherapy ProtocolsLeukemia, Myelomonocytic, AcuteTime FactorsHematopoiesisHistocompatibilityBone Marrow DiseasesSurvival RateDaunorubicinTransplantation, IsogeneicBone Marrow ExaminationDisease-Free SurvivalFatal OutcomeImmunosuppressive AgentsKidney TransplantationMice, Inbred C57BLHematologic NeoplasmsFollow-Up StudiesKaryotypingStem Cell TransplantationLeukemia, LymphoidRadiation ChimeraAntineoplastic AgentsBlast CrisisCell DifferentiationIdarubicinHepatic Veno-Occlusive DiseaseLeukemia, ExperimentalCytogenetic AnalysisGraft RejectionColony-Forming Units AssayLeukemia, Lymphocytic, Chronic, B-CellFlow CytometryBone RemodelingEtoposideFusion Proteins, bcr-ablBone Marrow NeoplasmsImmunophenotypingLeukemia, Monocytic, AcuteLymphoma, Non-HodgkinAntigens, CD34Core Binding Factor Alpha 2 SubunitLeukocyte TransfusionLymphocyte DepletionT-LymphocytesNeoplasm, ResidualTransplantation ImmunologyGraft vs Host ReactionHL-60 CellsGranulocyte Colony-Stimulating FactorImmunosuppressionTranslocation, GeneticActuarial AnalysisCytogeneticsChimeraHLA AntigensGraft vs Leukemia EffectOncogene Proteins, FusionLeukocyte CountHeart TransplantationHematologic DiseasesCyclosporineLymphocyte TransfusionSevere Combined Immunodeficiency